Plasminogen activator inhibitor
From Proteopedia
(Difference between revisions)
| Line 19: | Line 19: | ||
**[[4ic0]] - hPAI-1 (mutant) + gallate<br /> | **[[4ic0]] - hPAI-1 (mutant) + gallate<br /> | ||
**[[3ut3]] - hPAI-1 (mutant) + inhibitor<br /> | **[[3ut3]] - hPAI-1 (mutant) + inhibitor<br /> | ||
| - | **[[ | + | **[[4aqh]] - hPAI-1 + inhibitor<br /> |
**[[1oc0]] - hPAI-1 (mutant) + vitronectin<br /> | **[[1oc0]] - hPAI-1 (mutant) + vitronectin<br /> | ||
**[[3pb1]] - hPAI-1 (mutant) + urokinase (mutant)<br /> | **[[3pb1]] - hPAI-1 (mutant) + urokinase (mutant)<br /> | ||
Revision as of 10:34, 17 May 2015
Plasminogen activator inhibitor (PAI) is a serine protease inhibitor.
- PAI-1 inhibits tissue plasminogen activator and urokinase.
- PAI-2 is secreted by the placenta and is present during pregnancy.
- PAI-3 inhibits enzymes in blood coagulation.
3D Structures of plasminogen activator inhibitor
Updated on 17-May-2015
